Market Research - N/A, QC, CA
Katherine Borden's team seeks to shed light on how cells become cancerous. It particularly focuses on the disconnect between the transcriptome and the proteome. Her team focuses on dysregulated RNA processing as a major driver of this connect and explores its impacts in cancer. Further, her team, strives to leverage novel findings in RNA biochemistry in the clinic.
ASP.NET
Microsoft-IIS
GoDaddy Hosting